Wednesday, December 18, 2024
HomeTagsLysogene

Lysogene

Lysogene Secures a €4.3 Million Non-dilutive Financing From Bpifrance to Support Its Development

Lysogene, a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, announced that it has secured a €4.3 million non-dilutive financing...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics